Clinicopathological Characteristics, Treatment, and Prognosis of 21 Patients with Primary Gastric Squamous Cell Carcinoma

Table 2

Clinicopathological characteristics and survival outcomes of 21 patients with PGSCC.

Number	TNM stage	Depth of invasion	Metastasis of regional LN	Distant metastasis	Treatment	Outcomes (months)
1	IV	T4b	N2	M1	P	Death (6)
2	IIIB	T4b	N0	M0	R + A	Death (5)
3	IIB	T3	N1	M0	R + A	Alive (12)
4	IV	T4a	N2	M1	P	Death (1)
5	IV	T4b	N1	M1	No	Death (2)
6	IIA	T3	N0	M0	No	Death (5)
7	IIA	T3	N0	M0	R + A	Alive (60)
8	IIA	T3	N0	M0	R + A	Alive (45)
9	IIIC	T4b	N3	M0	R	Death (1)
10	IIB	T4a	N0	M0	No	Death (4)
11	IIIC	T4a	N3	M0	R	Death (50)
12	IB	T2	N0	M0	R	Alive (60)
13	IIIB	T4a	N2	M0	R	Alive (71)
14	IIA	T3	N0	M0	R + A	Alive (58)
15	IIA	T3	N0	M0	R + A	Alive (51)
16	IV	T3	N0	M1	R + A	Alive (51)
17	IIIA	T4a	N1	M0	R	Alive (46)
18	IIA	T3	N0	M0	R	Alive(43)
19	IIIB	T3	N3	M0	R	Alive (42)
20	IV	T4a	N0	M1	P	Death (6)
21	IIB	T3	N1	M0	R	Death (19)

PGSCC: primary gastric squamous cell carcinoma; LN: lymph nodes; P: palliative therapy; R: radical operation; A: adjuvant therapy.